Evidence map›Paper›PMID 35727505›Full record

ArticleProbiotics and antimicrobial proteins2022

Staphylococcus epidermidis WF2R11 Suppresses PM

Eulgi Lee, Hyeok Ahn, Shinyoung Park, Gihyeon Kim, Hyun Kim, Myung-Giun Noh, Yunjae Kim, Jae-Sung Yeon, Hansoo Park

Open access · hybridAbstract read
In one paragraph

Article in Probiotics and antimicrobial proteins, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Eulgi LeeDepartment of Biomedical Science and Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju, 61005, Republic of Korea.
Hyeok AhnDepartment of Biomedical Science and Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju, 61005, Republic of Korea.
Shinyoung ParkGenome and Company, Pangyo-ro 253, Bundang-gu, Seoungnam-si, Gyeonggi-do, 13486, Republic of Korea.
Gihyeon KimDepartment of Biomedical Science and Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju, 61005, Republic of Korea.
Hyun KimDepartment of Biomedical Science and Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju, 61005, Republic of Korea.
Myung-Giun NohDepartment of Biomedical Science and Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju, 61005, Republic of Korea.
Yunjae KimDepartment of Biomedical Science and Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju, 61005, Republic of Korea.
Jae-Sung YeonGenome and Company, Pangyo-ro 253, Bundang-gu, Seoungnam-si, Gyeonggi-do, 13486, Republic of Korea.
Hansoo ParkDepartment of Biomedical Science and Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju, 61005, Republic of Korea. hspark27@gist.ac.kr.ORCID 0000-0003-1027-8850
Gwangju Institute of Science and Technology · KRGenome and Company (South Korea) · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The skin supports a diverse microbiome whose imbalance is related to skin inflammation and diseases. Exposure to fine particulate matter (PM

Indexed as

Receptors, Aryl HydrocarbonStaphylococcus epidermidisHaCaT CellsHumansKeratinocytesParticulate MatterReactive Oxygen SpeciesParticulate MatterReactive Oxygen SpeciesReceptors, Aryl HydrocarbonAryl hydrocarbon receptorKeratinocyteParticulate matterSkin microbiomeStaphylococcus epidermidis

Identifiers

PMID35727505
PMCPMC9474527
OpenAlexW4283277602

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.